BICO Group AB engages in the provision of technologies, products, and services to create, understand, and master biology. The company is headquartered in Goeteborg, Vastra Gotalands and currently employs 695 full-time employees. The company went IPO on 2016-11-03. The firm focuses on the application areas of bioprinting, multiomics, cell line development, and diagnostics. The firm develops and markets technologies that enable researchers in the life sciences to culture cells in 3D, perform high-throughput drug screening and print human tissues and organs for the medical, pharmaceutical, and cosmetic industries. The Company’s operations divided in two segments: The Industrial Solutions segment that offers products within precision dispensing and biosensor technology for industrial customers, which make a high-capacity contribution to customers production; and The Laboratory Solutions segment that offers 3Dprinters, single- cell and liquid- dispensing instruments as well as services and consumables related to these products.
Follow-Up Questions
CLLKF hissesinin fiyat performansı nasıl?
CLLKF 'in mevcut fiyatı $2.55 'dir, son işlem günde 0% decreased etti.
BICO Group AB için ana iş temaları veya sektörler nelerdir?
BICO Group AB Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
BICO Group AB 'in piyasa değerlemesi nedir?
BICO Group AB 'in mevcut piyasa değerlemesi $176.4M 'dir
BICO Group AB al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 7 analist BICO Group AB için analist derecelendirmeleri gerçekleştirdi, bunlar 2 güçlü al, 6 al, 1 tut, 0 sat ve 2 güçlü sat içermektedir
